As Mermaid Medical exhibits at CIRSE 2023, we show our commitment to engage in healthcare innovations. We envision a future where medical technology not only meets but exceeds expectations, providing healthcare professionals with the tools they need to enhance patient outcomes.
Our Angel® Catheter has been honored with the Premier Breakthrough Innovation Award for the year 2023. This tribute not only recognizes the exceptional efforts of our dedicated team but also confirms our commitment to transforming healthcare and saving lives.
Now available to Premier members, D*Clot® HD is a system designed to raise the standard of safe and effective thrombectomy in patients with clotted AV fistulae or graft.
Mermaid Medical Group announces exclusive distribution agreement for BiopSafe in the United Kingdom.
Over two years of research, design, and development is finally culminating as Mermaid Medical Group introduces its new brand and visual identity.
Mermaid Medical Group announced today the appointment of former Marketing Director in Europe, Daniel Lennartz, as new Sales & Marketing Director in Europe.
Mermaid Medical Group announces commercial availability of D*Clot® HD Rotational Thrombectomy System to safely and effectively macerate and aspirate thrombus in AV fistulae and graft
Mermaid Medical announces the signing of a 3-year exclusive contract with CANYON in Spain, United Kingdom, and the Netherlands.